Peter Blume-Jensen stock trades
President and CEO of Acrivon Therapeutics
3 open-market trades reported in the last 3 months: 3 sales for $34K. One was held indirectly, as filed (through a trust, a fund, or another account). All 3 were filed jointly with another reporting owner. The newest was filed Aug 27.
Where Peter Blume-Jensen files
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 3 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 3 |
Peter Blume-Jensen's trades, as filed
Open-market buys and sales, newest first, each with its Form 4 on the SEC's site. A Plan tag marks a sale under a trading plan set up in advance.
| Stock | Traded |
|---|---|
| Aug 25SEC filing | |
| Aug 18SEC filing | |
| Aug 18SEC filing |
Pro members see every trade, the shares Peter Blume-Jensen held after each, and every filing.
Get in free →We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.